Home › Degenerative Nerve Diseases › Kansas
Degenerative Nerve Diseases clinical trials in Kansas
3 studies for Degenerative Nerve Diseases are looking for participants at sites in Kansas.
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- The University of Kansas - Clinical Research Center, Fairway
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #041, Overland Park
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- University of Kansas Medical Center, Kansas City
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Jul 27, 2026 · NCT04477785From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.